The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine

Abstract Bacillus Calmette–Guérin (BCG), the only vaccine proven to be effective against tuberculosis (TB), is the most commonly used vaccine globally. In addition to its effects on mycobacterial diseases, an increasing amount of epidemiological and experimental evidence accumulated since its introd...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junli Li, Lingjun Zhan, Chuan Qin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/546de3daadba442da33539035d701e32
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:546de3daadba442da33539035d701e32
record_format dspace
spelling oai:doaj.org-article:546de3daadba442da33539035d701e322021-12-02T13:57:25ZThe double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine10.1038/s41541-020-00278-02059-0105https://doaj.org/article/546de3daadba442da33539035d701e322021-01-01T00:00:00Zhttps://doi.org/10.1038/s41541-020-00278-0https://doaj.org/toc/2059-0105Abstract Bacillus Calmette–Guérin (BCG), the only vaccine proven to be effective against tuberculosis (TB), is the most commonly used vaccine globally. In addition to its effects on mycobacterial diseases, an increasing amount of epidemiological and experimental evidence accumulated since its introduction in 1921 has shown that BCG also exerts non-specific effects against a number of diseases, such as non-mycobacterial infections, allergies and certain malignancies. Recent Corona Virus Disease 2019 (COVID-19) outbreak has put BCG, a classic vaccine with significant non-specific protection, into the spotlight again. This literature review briefly covers the diverse facets of BCG vaccine, providing new perspectives in terms of specific and non-specific protection mechanisms of this old, multifaceted, and controversial vaccine.Junli LiLingjun ZhanChuan QinNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Junli Li
Lingjun Zhan
Chuan Qin
The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
description Abstract Bacillus Calmette–Guérin (BCG), the only vaccine proven to be effective against tuberculosis (TB), is the most commonly used vaccine globally. In addition to its effects on mycobacterial diseases, an increasing amount of epidemiological and experimental evidence accumulated since its introduction in 1921 has shown that BCG also exerts non-specific effects against a number of diseases, such as non-mycobacterial infections, allergies and certain malignancies. Recent Corona Virus Disease 2019 (COVID-19) outbreak has put BCG, a classic vaccine with significant non-specific protection, into the spotlight again. This literature review briefly covers the diverse facets of BCG vaccine, providing new perspectives in terms of specific and non-specific protection mechanisms of this old, multifaceted, and controversial vaccine.
format article
author Junli Li
Lingjun Zhan
Chuan Qin
author_facet Junli Li
Lingjun Zhan
Chuan Qin
author_sort Junli Li
title The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
title_short The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
title_full The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
title_fullStr The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
title_full_unstemmed The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
title_sort double-sided effects of mycobacterium bovis bacillus calmette–guérin vaccine
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/546de3daadba442da33539035d701e32
work_keys_str_mv AT junlili thedoublesidedeffectsofmycobacteriumbovisbacilluscalmetteguerinvaccine
AT lingjunzhan thedoublesidedeffectsofmycobacteriumbovisbacilluscalmetteguerinvaccine
AT chuanqin thedoublesidedeffectsofmycobacteriumbovisbacilluscalmetteguerinvaccine
AT junlili doublesidedeffectsofmycobacteriumbovisbacilluscalmetteguerinvaccine
AT lingjunzhan doublesidedeffectsofmycobacteriumbovisbacilluscalmetteguerinvaccine
AT chuanqin doublesidedeffectsofmycobacteriumbovisbacilluscalmetteguerinvaccine
_version_ 1718392321003749376